Skip to main content

Utility of the Determination of Biomarkers of Bone Metabolism

  • Chapter
  • First Online:

Abstract

Biochemical serum markers of bone metabolism are substances involved in all processes of bone activity. Systemic dispersion is the basis for their biochemical measurements. Both serum/plasma and urine measurements are widely used for clinical parameters of bone turnover, but accurateness and usability have favoured blood analyses over the years. This review will therefore focus on serum/plasma parameters of bone metabolism and their clinical applications and give hints on further applications within biological material.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Bauer D, Garnero P, Hochberg MC, for the Fracture Intervention Research Group (2006) Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res 21:292–299

    Google Scholar 

  • Bauer D, Krege J, Lane N, Leary E, Libanati C, Miller P, Myers G, Silverman S, Vesper HW, Lee D, Payette M, Randall S (2012) National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int 23(10):2425–2433

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bieglmayer C, Kudlacek S (2009) The bone marker plot: an innovative method to assess bone turnover in women. Eur J Clin Invest 39(3):230–238

    Article  CAS  PubMed  Google Scholar 

  • Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C (2002) Mechanism of circadian variation in bone resorption. Bone 30(1):307–313

    Article  CAS  PubMed  Google Scholar 

  • Black DM, Delmas PD, Eastell R (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822

    Article  CAS  PubMed  Google Scholar 

  • Blumsohn A, Marin F, Nickelsen T, Brixen K, Sigurdsson G, González de la Vera J, Boonen S, Liu-Léage S, Barker C, Eastell R; EUROFORS Study Group (2011) Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide. Osteoporos Int 22(6):1935–1946

    Google Scholar 

  • Bonewald LF (2007) Osteocyte messages from a bony tomb. Cell Metab 5:410–411

    Article  CAS  PubMed  Google Scholar 

  • Chao T-Y, Yi-Ying W, Janckila AJ (2010) Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis. Clin Chim Acta 411:1553–1564

    Article  CAS  PubMed  Google Scholar 

  • Clowes JA, Peel NF, Eastell R (2004) The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 89:1117–1123

    Article  CAS  PubMed  Google Scholar 

  • Dachverband Osteologie e.V (2014) Prophylaxe, Diagnostik und Therapie der OSTEOPOROSE bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen. S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften. Available at: http://www.dv-osteologie.org/dvo_leitlinien/osteoporose-leitlinie-2014

  • Drake MT, Srinivasan B, Moedder U, Peterson J, McCready L, Riggs BL, Dwyer D, Stolina M, Kostenuik PJ, Khosla S (2010) Intermittent PTH treatment decreases circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab 95(11):5056–5062

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eastell R, Robins SP, Colwell T, Assiri AM, Riggs BL, Russell RG (1993) Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 3(5):255–260

    Article  CAS  PubMed  Google Scholar 

  • Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161–174

    Article  CAS  PubMed  Google Scholar 

  • Fahrleitner-Pammer A, Herberth J, Browning SR, Obermayer-Pietsch B, Wirnsberger G, Holzer H, Dobnig H, Malluche HH (2008) Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 23(11):1850–1858

    Article  CAS  PubMed  Google Scholar 

  • Fritchie K, Zedek D, Grenache DG (2009) The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia. Clin Chim Acta 402(1-2):146–149

    Article  CAS  PubMed  Google Scholar 

  • Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY Study. J Bone Miner Res 15:1526–1536

    Article  CAS  PubMed  Google Scholar 

  • Garnero P, Ferreras M, Karsdal MA, Nicamhlaoibh R, Risteli J, Borel O, Qvist P, Delmas PD, Foged NT, Delaissé JM (2003) The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res 18(5):859–867

    Article  CAS  PubMed  Google Scholar 

  • Hall CL, Keller ET (2006) The role of Wnts in bone metastases. Cancer Metastasis Rev 25:551–558

    Article  CAS  PubMed  Google Scholar 

  • Hassan MQ, Tye CE, Stein GS, Lian JB (2015) Non-coding RNAs: epigenetic regulators of bone development and homeostasis. Bone 81:746–756

    Article  CAS  PubMed  Google Scholar 

  • Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281

    Article  CAS  PubMed  Google Scholar 

  • Holzer G, Noske H, Lang T, Holzer L, Willinger U (2005) Soluble cathepsin K: a novel marker for the prediction of nontraumatic fractures? J Lab Clin Med 146(1):13–17

    Article  CAS  PubMed  Google Scholar 

  • Iba K, Takada J, Yamashita T (2004) The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metab 22(6):594–596

    Article  CAS  PubMed  Google Scholar 

  • Iwamoto J, Sato Y, Takeda T, Matsumoto H (2009) High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature. Nutr Res 29(4):221–228

    Article  CAS  PubMed  Google Scholar 

  • Jesudason D, Clifton P (2011) The interaction between dietary protein and bone health. J Bone Miner Metab 29(1):1–14

    Article  CAS  PubMed  Google Scholar 

  • Johansson H, Oden A, Kanis JA, McCloskey EV, Morris HA, Cooper C (2014) A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int 94:560–567

    Article  CAS  PubMed  Google Scholar 

  • Kanazawa I, Yano S, Yamaguchi T, Notsu Y, Nabika T, Sugimoto T (2010) Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus. Clin Endocrinol (Oxf) 73(4):463–468

    CAS  Google Scholar 

  • Kos K, Wilding JP (2010) SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol 6(4):225–235

    Article  CAS  PubMed  Google Scholar 

  • Lee JH, Choi JH, Kweon OJ, Park AJ (2015) Discrepancy between vitamin D total immunoassays due to various cross-reactivities. J Bone Metab 22(3):107–112

    Article  PubMed  PubMed Central  Google Scholar 

  • Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, Wong KC, Chan M, Lam CW, Chu FS, Wong KK, Leung PC, Kwok A (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36(8):1646–1652

    Article  PubMed  Google Scholar 

  • Liu Y, Shi Z, Silveira A, Liu J, Sawadogo M, Yang H, Feng X (2003) Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation. J Biol Chem 278(23):20603–20611

    Article  CAS  PubMed  Google Scholar 

  • Ljusberg J, Wang Y, Lång P, Norgård M, Dodds R, Hultenby K, Ek-Rylander B, Andersson G (2005) Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem 280(31):28370–28381

    Article  CAS  PubMed  Google Scholar 

  • Lomeo A, Bolner A (2000) Stability of several biochemical markers of bone metabolism. Clin Chem 46:1200–1202

    CAS  PubMed  Google Scholar 

  • MacCallum SG, Voegtlin C (1909) On the relation of tetany to the parathyroid glands and to calcium metabolism. J Exp Med 11:118–151

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Macdonald BT, Joiner DM, Yserman SM, Sharma P, Goldstein SA, He X, Hauschka PV (2007) Bone mass is inversely proportional to Dkk1 levels in mice. Bone 41:331–339

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A (2013) Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone 57(2):399–404

    Google Scholar 

  • Mirza FS, Padhi ID, Raisz LG, Lorenzo JA (2010) Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab 95(4):1991–1997

    Article  PubMed  PubMed Central  Google Scholar 

  • Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS, Eastell R (2016) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 27(1):21–31

    Article  CAS  PubMed  Google Scholar 

  • Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T, EUROFORS Investigators (2008) Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J Bone Miner Res 23(10):1591–1600

    Article  CAS  PubMed  Google Scholar 

  • Pelletier JP, Raynauld JP, Caron J, Mineau F, Abram F, Dorais M, Haraoui B, Choquette D, Martel-Pelletier J (2010) Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann Rheum Dis 69(12):2095–2101

    Article  CAS  PubMed  Google Scholar 

  • Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C (2002) Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31(1):57–61

    Article  CAS  PubMed  Google Scholar 

  • Ramon I, Kleynen P, Body JJ, Karmali R (2010) Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol 162(1):1–10

    Article  CAS  PubMed  Google Scholar 

  • Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 92(2):443–449

    Article  CAS  PubMed  Google Scholar 

  • Rennenberg RJ, de Leeuw PW, Kessels AG, Schurgers LJ, Vermeer C, van Engelshoven JM, Kemerink GJ, Kroon AA (2010) Calcium scores and matrix Gla protein levels: association with vitamin K status. Eur J Clin Invest 40(4):344–349

    Article  CAS  PubMed  Google Scholar 

  • Roberts HC, Knott L, Avery NC, Cox TM, Evans MJ, Hayman AR (2007) Altered collagen in tartrate-resistant acid phosphatase (TRAP)-deficient mice: a role for TRAP in bone collagen metabolism. Calcif Tissue Int 80(6):400–410

    Article  CAS  PubMed  Google Scholar 

  • Schett G, Kiechl S, Redlich K, Oberhollenzer F, Weger S, Egger G, Mayr A, Jocher J, Xu bQ, Pietschmann P, Teitelbaum S, Smolen J, Willeit J (2004) Soluble RANKL and risk of nontraumatic fracture. JAMA 291(9):1108–1113

    Article  CAS  PubMed  Google Scholar 

  • Schwetz V, Pieber T, Obermayer-Pietsch B (2012) The endocrine role of the skeleton: background and clinical evidence. Eur J Endocrinol 166(6):959–967

    Article  CAS  PubMed  Google Scholar 

  • Seibel MJ (2006) Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis. Clin Biochem Rev 27:123–138

    PubMed  PubMed Central  Google Scholar 

  • Souberbielle JC, Cavalier E, Jean G (2010a) Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory? Clin Chem Lab Med 48(6):769–774

    Article  CAS  PubMed  Google Scholar 

  • Souberbielle JC, Roth H, Fouque DP (2010b) Parathyroid hormone measurement in CKD. Kidney Int 77(2):93–100

    Article  CAS  PubMed  Google Scholar 

  • Taylor AF, Saunders MM, Shingle DL, Cimbala JM, Zhou Z, Donahue HJ (2007) Mechanically stimulated osteocytes regulate osteoblastic activity via gap junctions. Am J Physiol 292:C545–C552

    Article  CAS  Google Scholar 

  • Terpos E (2006) Biochemical markers of bone metabolism in multiple myeloma. Cancer Treat Rev 32:15–19

    Article  CAS  PubMed  Google Scholar 

  • Ulbing M, Obermayer-Pietsch B (2015) MicroRNAs in bone, overview and clinical significance. Osteologie 24:219–224

    Google Scholar 

  • Ureña Torres P (2006) The need for reliable serum parathyroid hormone measurements. Kidney Int 70(2):240–243

    Article  PubMed  Google Scholar 

  • Uzum AK, Salman S, Telci A, Boztepe H, Tanakol R, Alagol F, Ozbey NC (2010) Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term. Eur J Endocrinol 163(5):825–831

    Article  CAS  PubMed  Google Scholar 

  • Vasikaran SR, Eastell O, Bruyere AJ, Foldes P, Garnero A, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA; IOF-IFCC Bone Marker Standards Working Group (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22(2):391–420

    Google Scholar 

  • Wang WM, Ge GX, Lim NH, Nagase H, Greenspan DS (2006) TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2. Biochem J 398(3):515–519

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Whyte MP (2010) Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 1192:190–200

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barbara Obermayer-Pietsch MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Obermayer-Pietsch, B., Schwetz, V. (2016). Utility of the Determination of Biomarkers of Bone Metabolism. In: Pietschmann, P. (eds) Principles of Osteoimmunology. Springer, Cham. https://doi.org/10.1007/978-3-319-34238-2_6

Download citation

Publish with us

Policies and ethics